We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genome Sequencing Increases Sensitivity of Carrier Screens

By LabMedica International staff writers
Posted on 23 May 2018
Traditionally, carrier screening has focused on specific disorders that are known to have a higher prevalence in certain ethnic populations. More...
More recently, lower sequencing costs coupled with higher accuracy of next generation sequencing-based methodologies have made it affordable for clinical laboratories to offer screening for substantially more conditions.

Massively parallel sequencing or next-generation sequencing (NGS) has provided the technical means to not only screen the full gene, but also analyze multiple genes and multiple individuals simultaneously, as compared to the targeted mutation panel approach of traditional carrier screening. However, given the rapid pace of its application, there is a paucity of information on the downstream impact of NGS in the healthcare system and in routine medical care.

A large team of scientists collaborating with their colleagues at the Oregon Health & Science University (Portland, OR, USA) first sequenced the genomes of 131 women, all members of the Kaiser Permanente Northwest healthcare system. For those with a positive carrier result, the scientists invited their male partners to get tested, resulting in 71 additional genomes sequenced. The team analyzed the data for variants in 728 genes related to inherited disease, including autosomal-recessive and X-linked conditions. They included lifespan-limiting, serious, mild, unpredictable, and adult-onset disorders. In addition, they looked for medically actionable variants, so-called secondary findings, in 148 genes, which included the American College of Medical Genetics and Genomics' 59-gene list.

The investigators extracted DNA from the participant’s blood and processed for sequencing using the Illumina TruSeq DNA LT kit. The DNA sample was sequenced on a HiSeq 2000 or 2500 (Illumina, version 3 chemistry) with 100 base pair, paired-end reads. The sequenced fragments were assessed for quality and aligned to the NCBI reference genome (GRCh37/hg19) to generate BAM files. Single-Nucleotide Variants (SNV) and Small Insertion and Deletions (Indel) were assigned. Structural variant analysis of the sequencing data were defined that included 2,000 nucleotides upstream and downstream of the first and last exon in the longest transcript. Tertiary Analysis and Variant Confirmation for SNVs and CNVs were also performed.

The scientists reported the results were in two phases: first the carrier results and later the medically actionable secondary findings. All participants received results for the lifespan-limiting conditions of the carrier screen, whereas the other results were optional. Of note, 93% of participants opted to receive all categories of carrier results, and 99% asked for their medically actionable secondary findings. Of the 202 participants, 78% received at least one positive carrier result, and the number of variants reported per person range from zero to five.

Twelve of the 71 couples tested turned out to be carriers for the same condition, and three women were carriers for an X-linked condition. Seven individuals, or 3.5% of participants, received secondary findings, and all but one of these would have been picked up by the American College of Medical Genetics and Genomics (ACMG)-59 list. The analysis also resulted in 808 variants of unknown significance, an average of four per person, which were not reported.

The authors concluded that overall, next-gen-sequencing-based carrier screening panels can detect rarer and novel pathogenic variants than traditional mutation screening panels that are designed for specific ethnic groups, and whole-genome sequencing can get around some of the biases and errors associated with targeted sequencing, and provide better structural variant detection. The study was published on May 10, 2018, in the journal American Journal of Human Genetics.

Related Links:
Oregon Health & Science University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.